Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,126
Total Claims
$1.4M
Drug Cost
753
Beneficiaries
$1,873
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-51%
Opioid rate vs peers
1.1% vs 2.2% avg
+33%
Cost per patient vs peers
$1,873 vs $1,411 avg
+18%
Brand preference vs peers
12.5% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.1%
Opioid Rate
121
Opioid Claims
$868
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,380 claims · $1.2M
Generic: 9,646 claims · $244K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Interferon Beta-1a/Albumin | 14 | $150K |
| Apixaban | 119 | $142K |
| Sitagliptin Phosphate | 99 | $130K |
| Rivaroxaban | 56 | $58K |
| Insulin Glargine,hum.Rec.Anlog | 36 | $50K |
| Elviteg/Cob/Emtri/Tenof Alafen | 12 | $49K |
| Fluticasone/Umeclidin/Vilanter | 36 | $47K |
| Evolocumab | 51 | $42K |
| Insulin Glargine,hum.Rec.Anlog | 33 | $33K |
| Empagliflozin | 18 | $31K |
| Semaglutide | 27 | $30K |
| Budesonide/Glycopyr/Formoterol | 25 | $30K |
| Fluticasone Propion/Salmeterol | 33 | $24K |
| Insulin Detemir | 14 | $24K |
| Sacubitril/Valsartan | 16 | $21K |
Prescribing Profile
Patient Profile
72
Avg Age
54%
Female
1.90
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data